1. Home
  2. XBIT vs TLS Comparison

XBIT vs TLS Comparison

Compare XBIT & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.37

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.08

Market Cap

358.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
TLS
Founded
2005
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
358.4M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
XBIT
TLS
Price
$2.37
$4.08
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.90
AVG Volume (30 Days)
27.1K
858.1K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.51
EPS
N/A
0.03
Revenue
N/A
$164,805,000.00
Revenue This Year
N/A
$18.72
Revenue Next Year
N/A
$14.62
P/E Ratio
N/A
$148.67
Revenue Growth
N/A
52.21
52 Week Low
$2.09
$2.37
52 Week High
$3.61
$8.36

Technical Indicators

Market Signals
Indicator
XBIT
TLS
Relative Strength Index (RSI) 39.06 40.34
Support Level $2.26 $3.88
Resistance Level $2.69 $4.65
Average True Range (ATR) 0.07 0.34
MACD -0.01 -0.05
Stochastic Oscillator 10.34 0.00

Price Performance

Historical Comparison
XBIT
TLS

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About TLS Telos Corporation

Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.

Share on Social Networks: